Preoperative chemoradiotherapy with the TEGAFIRI regimen achieves significant local control in locally advanced rectal cancer
The TEGAFIRI regimen for preoperative CRT in LARC demonstrated a high pCR rate and reduced local recurrence, with manageable adverse events.
Authors
- Soichiro Ishihara (ORCID: https://orcid.org/0000-0003-0543-0045)
- Koji Oba (ORCID: https://orcid.org/0000-0001-5468-8988)
- Yuichi Tachikawa (ORCID: https://orcid.org/0000-0002-8052-6867)
- Kazushige Kawai (ORCID: https://orcid.org/0000-0002-5881-0036)
- Koji Murono (ORCID: https://orcid.org/0000-0002-4184-5443)
- Kazuhito Sasaki (ORCID: https://orcid.org/0000-0003-3569-6944)
- Yuichiro Yokoyama (ORCID: https://orcid.org/0000-0003-4578-4454)
- Shinya Abe (ORCID: https://orcid.org/0000-0002-2432-3141)
- Shigenobu Emoto (ORCID: https://orcid.org/0000-0002-6146-9385)
- Hiroaki Nozawa (ORCID: https://orcid.org/0000-0002-7891-5986)
- Yuzo Nagai (ORCID: https://orcid.org/0000-0002-8415-5661)
- Satoshi Okada (ORCID: https://orcid.org/0000-0003-1514-3031)
- Kensuke Kaneko (ORCID: https://orcid.org/0000-0003-0510-4602)
- Takahide Shinagawa (ORCID: https://orcid.org/0000-0003-3790-7047)
Institutions
- Tokyo Metropolitan Komagome Hospital (JP)
- University of Tokyo Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- International Journal of Colorectal Disease
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1007/s00384-025-04867-0
- Citations
- 2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- University of Tokyo
- Japan Society for the Promotion of Science